<VariationArchive RecordType="classified" VariationID="657915" VariationName="NC_000006.12:g.(?_131576653)_(131583918_?)del" VariationType="Deletion" Accession="VCV000657915" Version="6" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-11" DateCreated="2019-08-14" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="651480" VariationID="657915">
      <GeneList>
        <Gene Symbol="ARG1" FullName="arginase 1" GeneID="383" HGNC_ID="HGNC:663" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="131573226" stop="131584329" display_start="131573226" display_stop="131584329" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="131894343" stop="131905471" display_start="131894343" display_stop="131905471" Strand="+" />
          </Location>
          <OMIM>608313</OMIM>
        </Gene>
        <Gene Symbol="MED23" FullName="mediator complex subunit 23" GeneID="9439" HGNC_ID="HGNC:2372" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="131573966" stop="131628313" display_start="131573966" display_stop="131628313" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="131895105" stop="131949378" display_start="131895105" display_stop="131949378" Strand="-" />
          </Location>
          <OMIM>605042</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000006.12:g.(?_131576653)_(131583918_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q23.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" innerStart="131576653" innerStop="131583918" display_start="131576653" display_stop="131583918" variantLength="7266" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" innerStart="131897793" innerStop="131905058" display_start="131897793" display_stop="131905058" variantLength="7266" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.(?_131897793)_(131905058_?)del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.(?_131897793)_(131905058_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.(?_131576653)_(131583918_?)del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.(?_131576653)_(131583918_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000006.12:g.(?_131576653)_(131583918_?)del AND Arginase deficiency" Accession="RCV000814626" Version="6">
        <ClassifiedConditionList TraitSetID="604">
          <ClassifiedCondition DB="MedGen" ID="C0268548">Arginase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-12" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-08-14" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1463019</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15565656</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="604" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4607" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Arginase deficiency</ElementValue>
                <XRef ID="Arginase+Deficiency/574" DB="Genetic Alliance" />
                <XRef ID="23501004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ARG1 deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Argininemia</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Arginase deficiency in untreated individuals is characterized by episodic hyperammonemia of variable degree that is infrequently severe enough to be life threatening or to cause death. Most commonly, birth and early childhood are normal. Untreated individuals have slowing of linear growth at age one to three years, followed by development of spasticity, plateauing of cognitive development, and subsequent loss of developmental milestones. If untreated, arginase deficiency usually progresses to severe spasticity, loss of ambulation, complete loss of bowel and bladder control, and severe intellectual disability. Seizures are common and are usually controlled easily. Individuals treated from birth, either as a result of newborn screening or having an affected older sib, appear to have minimal symptoms.</Attribute>
                <XRef ID="NBK1159" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5840" />
                <XRef ID="5840" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301338</ID>
                <ID Source="BookShelf">NBK1159</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301396</ID>
                <ID Source="BookShelf">NBK1217</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, Argininemia 2022">
                <URL>https://www.acmg.net/PDFLibrary/Arginine.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, [Increased Arginine] Argininemia, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Arginine-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Arginine Elevated Algorithm, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Arginase-Deficiency-Transition.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Transition to Adult Health Care ACT Sheet, Arginase Deficiency (argininemia, hyperargininemia, ARG1 deficiency), Urea Cycle Disorder, 2012</CitationText>
              </Citation>
              <XRef ID="90" DB="Orphanet" />
              <XRef ID="C0268548" DB="MedGen" />
              <XRef ID="MONDO:0008814" DB="MONDO" />
              <XRef Type="MIM" ID="207800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1849227" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="NM_000045.3_6_Deletion (exons 2-8)|MedGen:C0268548" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000955040" DateUpdated="2023-11-11" DateCreated="2019-08-14" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15565656</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1463019</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 2-8 of the ARG1 gene, which includes the termination codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product. A similar copy number variant has been observed in individual(s) with arginase deficiency (PMID: 15565656). This variant disrupts a region of the ARG1 protein in which other variant(s) (p.Leu282Trpfs*8) have been determined to be pathogenic (PMID: 1463019). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ARG1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.(?_131897793)_(131905058_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268548" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1849227" TraitType="Disease" MappingType="XRef" MappingValue="C0268548" MappingRef="MedGen">
        <MedGen CUI="C0268548" Name="Arginase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

